healthcare
Top StoriesAstraZeneca Signs $2 Billion Agreement With Quell to Develop Cell Therapies
FinanceHealth Savings Accounts (hsas): How to Use Hsas for Healthcare Expenses and Retirement Savings
Top StoriesCeline Dion Cancels Rest of World Tour Due to Medical Condition
Top StoriesFrance Confirms Bird Flu Vaccination After Favourable Tests
Elon Musk’s Neuralink Says Has Fda Approval for Study of Brain Implants in Humans
Date: May 26, 2023
Elon Musk’s Neuralink says has FDA approval for study of brain implants in humans By Akriti Sharma and Rachael Levy (Reuters) – Elon Musk’s brain-implant company Neuralink on Thursday said the U.S. Food and Drug Administration (FDA) had given the green light to its first-in-human clinical trial, a critical milestone after earlier struggles to gain...
Denmark to Boost Healthcare With an Extra $739 Million per Year
Date: May 23, 2023
COPENHAGEN (Reuters) -Denmark will use stronger-than-expected economic growth to boost its healthcare system with an extra 5 billion Danish crowns ($739 million) per year, the country’s Prime Minister Mette Frederiksen said on Tuesday. Danes pay some of the highest taxes in the world to finance their welfare model, which includes universal healthcare. But as the...
Tests Clear Recalled Philips Sleep Apnoea Machines of Health Risks -Company
Date: May 16, 2023
Tests clear recalled Philips sleep apnoea machines of health risks -company AMSTERDAM (Reuters) -Dutch medical devices maker Philips said on Tuesday that independent tests have shown that the use of its respiratory devices involved in a major global recall did not cause health risks for patients. Philips said “rigorous testing” by external parties on the...
Novo Nordisk Cuts Some US Supply of Obesity Drug Wegovy to Cope With Demand
Date: May 4, 2023
Novo Nordisk cuts some US supply of obesity drug Wegovy to cope with demand By Nikolaj Skydsgaard COPENHAGEN (Reuters) -Danish drug developer Novo Nordisk said it would have to halve the supply of starter doses of its popular Wegovy weight-loss drug in the United States to cope with high demand after reporting forecast-beating results on...
Gsk Bets $2 Billion on Bellus Cough Drug to Soothe Pipeline Fears
Date: April 18, 2023
GSK bets $2 billion on Bellus cough drug to soothe pipeline fears By Natalie Grover and Aby Jose Koilparambil (Reuters) -GSK plans to buy Canada-based drug developer Bellus Health Inc in an all-cash deal for $2 billion as the British drugmaker expands its bet on respiratory therapies. The move to replenish its pipeline comes as...
Agnellis’ Exor Eyes Further Healthcare Investment for Expansion
Date: April 17, 2023
Agnellis’ Exor eyes further healthcare investment for expansion By Giulio Piovaccari MILAN (Reuters) -Exor the holding company of Italy’s Agnelli family, will seek further opportunities to expand in healthcare after investing almost one billion euros ($1.1 billion) in the industry last year, CEO John Elkann said on Monday. After completing the sale of its reinsurer...